News + Filings Transactions
|
Cheng Andrew
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/02/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 8.9k | $46.06 | $408.4k | | 10/02/2023 |
| 10/02/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 5.3k | $46.88 | $248.5k | | 10/02/2023 |
| 10/02/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 2.7k | $48.56 | $129.3k | | 10/02/2023 |
| 10/02/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1.7k | $49.71 | $84.5k | | 10/02/2023 |
| 10/02/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 6.5k | $50.56 | $327.1k | | 10/02/2023 |
| 10/02/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 25k | $6.36 | $159k | | 10/02/2023 |
| 08/01/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 13.7k | $42.85 | $586.2k | | 08/01/2023 |
| 08/01/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 11.3k | $43.52 | $492.7k | | 08/01/2023 |
| 08/01/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 25k | $6.36 | $159k | | 08/01/2023 |
| 07/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 18.7k | $44.66 | $836.5k | | 07/03/2023 |
| 07/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 5.1k | $45.36 | $229.1k | | 07/03/2023 |
| 07/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1.2k | $46.29 | $56.4k | | 07/03/2023 |
| 07/03/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 25k | $6.36 | $159k | | 07/03/2023 |
| 06/13/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1.6k | $55.16 | $89k | | 06/13/2023 |
| 06/01/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 3.7k | $6.36 | $23.3k | | 06/01/2023 |
| 06/01/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 21.3k | $0.62 | $13.1k | | 06/01/2023 |
| 06/01/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 400 | $45.90 | $18.4k | | 06/01/2023 |
| 06/01/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 20.7k | $45.26 | $936.2k | | 06/01/2023 |
| 06/01/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.9k | $44.18 | $172.9k | | 06/01/2023 |
| 05/01/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 25k | $0.62 | $15.4k | | 04/18/2023 |
| 05/01/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.5k | $45.50 | $158.2k | | 04/18/2023 |
| 05/01/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 21.5k | $45.00 | $968.6k | | 04/18/2023 |
| 04/18/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 40k | $0.62 | $24.6k | | 04/18/2023 |
| 04/03/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 25k | $0.62 | $15.4k | | 04/03/2023 |
| 04/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1.7k | $38.83 | $66.3k | | 04/03/2023 |
| 04/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 23.3k | $37.88 | $882.3k | | 04/03/2023 |
| 03/10/2023 | Akero Therapeutics, Inc. | AKRO | Payment of Exercise | Common Stock | 1.7k | $43.47 | $74.2k | | 03/10/2023 |
| 01/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 13.2k | $50.12 | $661.6k | | 01/03/2023 |
| 01/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.8k | $50.82 | $193.1k | | 01/03/2023 |
| 01/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.9k | $54.37 | $212k | | 01/03/2023 |
| 01/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 300 | $54.81 | $16.4k | | 01/03/2023 |
| 01/03/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 25k | $0.62 | $15.4k | | 01/03/2023 |
| 01/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3k | $52.03 | $156.1k | | 01/03/2023 |
| 01/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 800 | $53.09 | $42.5k | | 01/03/2023 |
| 12/16/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 87.2k | $21.10 | $1.8M | | 12/16/2022 |
|
|